Brevan Howard Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-56,749
| Closed | -$1.04M | – | 1078 |
|
|
2024
Q4 | $1.04M | Buy |
56,749
+43,270
| +321% | +$794K | 0.01% | 392 |
|
|
2024
Q3 | $207K | Sell |
13,479
-19,857
| -60% | -$305K | ﹤0.01% | 929 |
|
|
2024
Q2 | $542K | Sell |
33,336
-513
| -2% | -$8.34K | ﹤0.01% | 531 |
|
|
2024
Q1 | $626K | Buy |
33,849
+16,039
| +90% | +$297K | 0.01% | 340 |
|
|
2023
Q4 | $558K | Buy |
+17,810
| New | +$558K | 0.01% | 387 |
|